This brand name is authorized in Cyprus, Israel, Lithuania, Malta
The drug HEMAFER contains one active pharmaceutical ingredient (API):
|
1
Ferric hydroxide polymaltose complex
UNII 2UA751211N - FERRIC HYDROXIDE
|
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| B03AB04 | Ferric hydroxide | B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations → B03AB Iron trivalent, oral preparations |
| B03AB05 | Ferric oxide polymaltose complexes | B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations → B03AB Iron trivalent, oral preparations |
| B03AC | Iron trivalent, parenteral preparations | B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 5514 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1083703, 1089626 |
| Country: MT | Medicines Authority | Identifier(s): AA1096/00101 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
